- By insider

SVP, CFO and Treasurer of Acceleron Pharma Inc (30-Year Financial, Insider Trades) Kevin F Mclaughlin (insider trades) sold 7,472 shares of XLRN on 12/11/2020 at an average price of $125.02 a share. The total sale was $934,149.

• Warning! GuruFocus has detected 6 Warning Signs with XLRN. Click here to check it out.

• XLRN 15-Year Financial Data

• The intrinsic value of XLRN

• Peter Lynch Chart of XLRN

Acceleron Pharma Inc is a biotechnology company which focuses on discovery, development, and commercialization of novel therapies. It aims to discover key natural regulators of cellular growth and repair. Acceleron Pharma Inc has a market cap of $7.49 billion; its shares were traded at around $124.280000 with and P/S ratio of 64.12. GuruFocus has detected 3 severe warning signs with Acceleron Pharma Inc. .

CFO Recent Trades:

• SVP, CFO and Treasurer Kevin F Mclaughlin sold 7,472 shares of XLRN stock on 12/11/2020 at the average price of $125.02. The price of the stock has decreased by 0.59% since.

For the complete insider trading history of XLRN, click here

.This article first appeared on GuruFocus.